Pages that link to "Q41085122"
Jump to navigation
Jump to search
The following pages link to Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial (Q41085122):
Displaying 14 items.
- Drug interventions for the treatment of obesity in children and adolescents (Q28279770) (← links)
- The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial. (Q39013480) (← links)
- The MXL-3/SBP-1 Axis Is Responsible for Glucose-Dependent Fat Accumulation in C. elegans. (Q47099823) (← links)
- Microbiota and metabolic diseases. (Q53688571) (← links)
- New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT (Q57176979) (← links)
- Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study (Q58756822) (← links)
- The effects of metformin on insulin resistance in overweight or obese children and adolescents: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials (Q61809477) (← links)
- The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect (Q64095130) (← links)
- Increased Arterial Stiffness in Adolescents With Obesity (Q64105110) (← links)
- Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field (Q89047732) (← links)
- Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review (Q90236640) (← links)
- Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study (Q91843534) (← links)
- Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan (Q91875416) (← links)
- Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells (Q93111912) (← links)